logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Thomas U. Marron

Tisch Cancer Institute
H指数:41
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dendritic cells control tertiary lymphoid structure development and maintenance in cancer

树突状细胞调控肿瘤中三级淋巴样结构的发育与维持

Science
IF45.8
2026-07-160
PRE
Raphaël Mattiuz; Jesse Boumelha; Emmanouil Aerakis; Jessica Le Berichel; Pauline Hamon; Laszlo Halasz; Abishek Vaidya; Brian Y. Soong; Emir Radkevich; Hye Mi Kim; Matthew D. Park; Romain Donne; Leanna Troncoso; Rachel A. Kaplan; Clotilde Hennequin; Isaias Hernández-Verdin; Lucía López; Frederika Rentzeperis; Darwin D’Souza; Medard Ernest Kaiza; Ian P. MacFawn; Meriem Belabed; Guillaume Mestrallet; Etienne Humblin; Raphaël Merand; Samarth Hegde; Jean-Christophe Lone; Giorgio Ioannou; Sinem Ozbey; Igor Figueiredo; Alexander Tepper; Hajer Merarda; Nadine Serhan; Maximilian M. Schaefer; Jinping An; Ray A. Ohara; Erika Nemeth; Simon Goldstein; Amanda M. Reid; Moataz Noureddine; Alexandra Tabachnikova; Giulia Maria Piperno; Maria Tsoumakidou; Jalal Ahmed; Alexandros D. Polydorides; Nina Bhardwaj; Amaia Lujambio; Zhihong Chen; Edgar Gonzalez Kozlova; Seunghee Kim-Schulze; Joshua D. Brody; Michael Schotsaert; Christine Moussion; Sacha Gnjatic; Vladimir Roudko; Florent Ginhoux; Kenneth M. Murphy; Catherine Sautès-Fridman; Wolf Herman Fridman; Brian D. Brown; Thomas U. Marron; Federica Benvenuti; Jason G. Cyster; Hélène Salmon; Tullia C. Bruno; Nikhil S. Joshi; Alice O. Kamphorst; Miriam Merad
A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab Plus bevacizumab in hepatocellular caarcinoma.

髓系免疫抑制表型定义了肝细胞癌对阿替利珠单抗联合贝伐珠单抗的原发耐药性。

Journal of Hepatology
IF33
2026-06-150
OAAI
Pasquale Lombardi; Erik Ramon-Gil; Rabial Q. Raja; Leonardo Brunetti; Giulia Francesca Manfredi; Zhongguo Zhou; George Merces; Sarah Cappuyns; Claudia Angela Maria Fulgenzi; Antonio D’Alessio; Aria Torkpour; Ciro Celsa; Bernardo Stefanini; Hannah Yang; Fionnuala Crowley; Thomas U. Marron; Anwaar Saeed; Matthias Pinter; Bernhard Scheiner; Yi-Hsiang Huang
The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort study

使用高级机器学习方法预测阿替利珠单抗联合贝伐珠单抗治疗晚期肝细胞癌的结局：一项回顾性队列研究

The Lancet Digital Health
IF0
2026-02-120
OAAI
Mathew Vithayathil; Giulia Francesca Manfredi; Antonio D’Alessio; Claudia Angela Maria Fulgenzi; Ciro Celsa; Pasquale Lombardi; Aria Torkpour; Bernardo Stefanini; Peter R Galle; Naoshi Nishida; Bernhard Scheiner; Fionnuala Crowley; Linda Wu; Celina Ang; Thomas U Marron; Wei-Fan Hsu; Chun-Yen Lin; Ryan Po-Ting Lin; Susanna V Ulahannan; Haripriya Andanamala
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial

粪便菌群移植联合免疫治疗非小细胞肺癌和黑色素瘤: fmt-luminate 2期临床试验

Nature Medicine
IF50
2026-01-280
OAAI
Sreya Duttagupta; Meriem Messaoudene; Sebastian Hunter; Antoine Desilets; Rahima Jamal; Catalin Mihalcioiu; Wiam Belkaid; Nicolas Marcoux; Marine Fidelle; Deborah Suissa; Mayra Ponce; Mallia Geiger; Julie Malo; Gianmarco Piccinno; Michal Punčochář; Alysé Filin; Vitor Heidrich; Diana Rusu; Babacar Mbaye; Sylvere Durand; Imen Ben Aissa; Vadim Puller; Raynald de Lahondès; Normand Blais; Mustapha Tehfe; Scott Owen; Karl Bélanger; Seema Nair Parvathy; Benjamin Shieh; Jacques Raphael; John Lenehan; Daniel Breadner; Jeffrey Rothenstein; Nicholas Rozza; Jade Maillou; Somayeh Nili; Diogjena Katerina Prifti; Federica Pinto; Federica Armanini; Seunghee Kim-Schulze; Thomas U. Marron; Guido Kroemer; Lisa Derosa; Laurence Zitvogel; Michael Silverman; Nicola Segata; Saman Maleki Vareki; Bertrand Routy; Arielle Elkrief
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade

对肿瘤抗原的体液IgG1反应是免疫检查点阻断的临床结果的基础

Nature Medicine
IF50
2026-01-270
OAAI
Edgar Gonzalez-Kozlova; Robert Sweeney; Igor Figueiredo; Kevin Tuballes; Sinem Ozbey; Pauline Hamon; Matthew D. Park; Giorgio Ioannou; Yohei Nose; Ruiwei Guo; Paula Restrepo; Mark Buckup; Vladimir Roudko; Clotilde Hennequin; Jessica Le Berichel; Nicholas Venturini; Laszlo Halasz; Leanna Troncoso; Alexandra Tabachnikova; Christie Chang; Amanda Reid; Haley Brown; Theodore Chin; Rafael Cabal; Raphaël Mattiuz; Shingo Eikawa; Diane Marie Del Valle; Tina Ruth Gonsalves; Nelson M. LaMarche; Hajra Jamal; Alona Lansky; Nancy Yi; Daniella Nelson; Jarod Morgenroth-Rebin; Raphael Merand; Bryan Villagomez; Darwin D’Souza; Emir Radkevich; Kai Nie; Zhihong Chen; Yasuko Tada; Hiroyoshi Nishikawa; Stephen C. Ward; Maria Isabel Fiel; Rachel Brody; Parissa Tabrizian; Ganesh Gunasekaran; Alice O. Kamphorst; Noah Cohen; Maria Curotto de Lafaille; Olivia Hapanowicz; Natalie Lucas; Kathy Wu; Nicola James; John C. Lin; Gavin Thurston; Myron Schwartz; Nathalie Fiaschi; Seunghee Kim-Schulze; Miriam Merad; Thomas U. Marron; Sacha Gnjatic
A monoclonal antibody that inhibits the shedding of CD16a and CD16b and promotes antibody-dependent cellular cytotoxicity against tumors

一种抑制CD16a和CD16b脱落并促进抗肿瘤抗体依赖性细胞介导的细胞毒性作用的单克隆抗体

Nature Communications
IF15.7
2025-11-110
OAAI
Bruna Taciane da Silva Bortoleti; Sophia Quasem; Stefanie Maurer; Xiaoxuan Zhong; Ruan Pimenta; Luiza Ribeiro de Lima Brandão; Matthew Hernandez; Melanie Fraidenburg; Pedro Henrique Alves da Silva; Raymond Alvarez; Benjamin K. Chen; Márcio Augusto Diniz; Brian Housman; Raja M. Flores; Rachel Brody; Thomas U. Marron; Lucas Ferrari de Andrade
Lenvatinib versus sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: the LEVIATHAN Study

伦伐替尼对比索拉非尼作为阿替利珠单抗联合贝伐珠单抗后肝癌的二线治疗：LEVIATHAN 研究

JHEP Reports
IF7.5
2025-09-230
OAAI
Pasquale Lombardi; Jung Sun Kim; Giulia F. Manfredi; Ciro Celsa; Claudia A.M. Fulgenzi; Antonio D’Alessio; Bernardo Stefanini; Niraj C. Doshi; Emily Warmington; Thomas U. Marron; Matthias Pinter; Bernhard Scheiner; Beodeul Kang; Ho Yeong Lim; Wei-Fan Hsu; Brooke Wietharn; Marianna Silletta; Alessandro Parisi; Chun-Yen Lin; Andrea Dalbeni; Gianluca Masi; Martin Schönlein; Johann von Felden; Fabio Piscaglia; Peter R. Galle; Masatoshi Kudo; Tiziana Pressiani; Lorenza Rimassa; Mario Pirisi; Giuseppe Cabibbo; Hong Jae Chon; David J. Pinato
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours

髓系祖细胞失调促进肿瘤中的免疫抑制性巨噬细胞

Nature
IF48.5
2025-09-100
PRE
Samarth Hegde; Bruno Giotti; Brian Y. Soong; Laszlo Halasz; Jessica Le Berichel; Maximilian M. Schaefer; Benoit Kloeckner; Raphaël Mattiuz; Matthew D. Park; Assaf Magen; Adam Marks; Meriem Belabed; Pauline Hamon; Theodore Chin; Leanna Troncoso; Juliana J. Lee; Kaili Fan; Dughan Ahimovic; Michael J. Bale; Kai Nie; Grace Chung; Darwin D’souza; Krista Angeliadis; Seunghee Kim-Schulze; Raja M. Flores; Andrew J. Kaufman; Florent Ginhoux; Jason D. Buenrostro; Steven Z. Josefowicz; Alexander M. Tsankov; Thomas U. Marron; Sai Ma; Brian D. Brown; Miriam Merad
Multiparametric cellular and spatial organization in cancer tissue lesions with a streamlined pipeline

癌症组织病变中的多参数细胞和空间组织及其简化流程

Nature Biomedical Engineering
IF26.6
2025-08-250
OAAI
Mark Buckup; Igor Figueiredo; Giorgio Ioannou; Sinem Ozbey; Rafael Cabal; Alexandra Tabachnikova; Leanna Troncoso; Jessica Le Berichel; Zhen Zhao; Stephen C. Ward; Clotilde Hennequin; Guray Akturk; Steve Hamel; Maria Isabel Fiel; Rachel Brody; Myron Schwartz; Thomas U. Marron; Seunghee Kim-Schulze; Vladimir Roudko; Edgar Gonzalez-Kozlova; Pauline Hamon; Miriam Merad; Sacha Gnjatic
Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma

肺大细胞神经内分泌癌的整合分子与临床特征分析

Nature Communications
IF15.7
2025-08-190
OA
Amin H. Nassar; Chul Kim; Tolulope Adeyelu; Elias Bou Farhat; Hassan Abushukair; Mehrdad Rakaee; Kelsey Matteson; Shun-Fat Lau; Yamato Takabe; Antonio Ocejo; Fatemeh Ardeshir-Larijani; Ticiana Leal; Suresh Ramalingam; Sumaiya Alam; Jhanelle E. Gray; James Hicks; David Kaldas; Javier Baena; Maria Zurera Berjaga; Frank Aboubakar Nana; Christian Grohe; Heike Leuders; Fabrizio Citarella; Alessio Cortellini; Emanuele Claudio Mingo; Danny Pancirer; Millie Das; Timothy John Ellis-Caleo; Justin M. Cheung; Jessica J. Lin; Alexander S. Watson; D. Ross Camidge; Arthi Sridhar; Kaushal Parikh; Fionnuala Crowley; Thomas U. Marron; Vanya Aggarwal; Murtaza Ahmed; Kamya Sankar; Hassan Kawtharany; Jun Zhang; Dwight H. Owen; Mingjia Li; Misako Nagasaka; David J. Pinato; Nichola Awosika; Khaled Alhamad; Sonam Puri; Unaiza Zaman; Divya M. Gupta; Chelsea Lau; Hina Khan; Justin Liauw; Ana I. Velazquez; Tyiesha Brown; Laura Moliner; Miguel Mosteiro; Pedro Rocha; Mark Evans; Ari Vanderwalde; Andrew Elliott; Jorge Nieva; Gilberto Lopes; Patrick C. Ma; Hossein Borghaei; Matthew Lee; Lauren Young; Raid Aljumaily; Haris Mirza; David J. Kwiatkowski; Roy S. Herbst; Richard A. Flavell; Abdul Rafeh Naqash; Anne C. Chiang
International guidelines on the diagnosis and treatment of NUT carcinoma

NUT癌的诊断与治疗国际指南

innovation
IF0
2025-07-310
OAAI
Yu Zhang; Qi Zhang; Yue Hao; Jia Luo; Yingshi Piao; Wenxian Wang; Zhengbo Song; Ziming Li; Luka Brcic; Aijun Liu; Jinpu Yu; Yasuhiro Tsutani; Wenzhao Zhong; Wenfeng Fang; Zhijie Wang; Shengxiang Ren; Athanasios G. Papavassiliou; Yongchang Zhang; Jingjing Liu; Shirong Zhang; Xiuyu Cai; Ayten Kayi Cangir; Anwen Liu; Wen Li; Filippo Lococo; Ping Zhan; Hongbing Liu; Tangfeng Lv; Liyun Miao; Lingfeng Min; Helmut Popper; Yu Chen; Jingping Yuan; Feng Wang; Zhansheng Jiang; Gen Lin; Long Huang; Xingxiang Pu; Rongbo Lin; Kalevi Kairemo; Weifeng Liu; Chuangzhou Rao; Dongqing Lv; Zongyang Yu; Ashrafian Leanne; Xiaoyan Li; Chuanhao Tang; Hifzur R. Siddique; Chengzhi Zhou; Junping Zhang; Junli Xue; Vishal Shelat; Hui Guo; Qian Chu; Rui Meng; Fatemeh Ardeshir; Jingxun Wu; Rui Zhang; Jin Zhou; Robert A. Kratzke; Zhengfei Zhu; Yongheng Li; Hong Qiu; Fan Xia; Fiorella Calabrese; Yang Xia; Alessandro Wasum Mariani; Yuanyuan Lu; Xiaofeng Chen; Mark A. Klein; Rui Ge; Enyong Dai; Axel H. Schönthal; Yu Han; Zhenying Guo; Jian Zhang; Yinghua Ji; Xianbin Liang; Hongmei Zhang; Xuelei Ma; Marco Chiappetta; Xuewen Liu; Francoise Galateau Salle; Yu Yao; Malgorzata Szolkowska; Weiwei Pan; Fei Pang; Fan Wu; Stefan B. Watzka; Liping Wang; Youcai Zhu; Li Lin; Aparna Sharma; Jianfei Tu; Xinqing Lin; Jing Cai; Ling Xu; Jisheng Li; Xiaodong Jiao; Kainan Li; Marjorie G. Zauderer; Jia Wei; Huijing Feng; Lin Wang; Yingying Du; Wang Yao; Elizabeth Dudnik; Xuefei Shi; Xiaomin Niu; Dongmei Yuan; Yanwen Yao; Jianhui Huang; Yue Feng; Yinbin Zhang; Binbin Song; Wenfeng Li; Jianfei Fu; Marina K. Baine; Pingli Sun; Hong Wang; Mingxiang Ye; Dong Wang; Zhaofeng Wang; Jing Wu; Yunyun Yang; Yuan Fang; Zhen Wang; Bin Wan; Donglai Lv; Huafei Chen; Shengjie Yang; Jing Kang; Jiatao Zhang; Chao Zhang; Lin Shi; Yina Wang; Mohamed Emam Sobeih; Bihui Li; Bin Lian; Lili Mao; Zhang Zhang; Ke Wang; Zhongwu Li; Zhefeng Liu; Nong Yang; Lin Wu; Xiaobing Chen; Gu Jin; Miao Li; Guansong Wang; Thomas U. Marron; Jiandong Wang; Sanjay Popat; Meiyu Fang; Yong Fang; Daniel Mansilla; Yuan Li; Xiaojia Wang; Jing Chen; Yiping Zhang; Xixu Zhu; Yi Shen; Shenglin Ma; Aaron S. Mansfield; Biyun Wang; Lu Si; Anja C. Roden; Bjørn H. Grønberg; Yong Song; Geoffrey I. Shapiro; Christopher A. French; Yuanzhi Lu; Qian Wang; Chunwei Xu
Tumor Immunophenotypic Correlates in Patients Aged 80 Years or Older With Non-Small Cell Lung Cancer and Outcomes to First-Line Pembrolizumab in PD-L1 High (≥50%) Patients

老年非小细胞肺癌患者（≥80岁）的肿瘤免疫表型相关性及PD-L1高表达（≥50%）患者接受一线帕博利珠单抗治疗的结局

Clinical Lung Cancer
IF3.3
2025-02-040
PRE
Adriana P.C. Barrichello; Arielle Elkrief; Biagio Ricciuti; Teja Ganta; Thomas U. Marron; Xinan Wang; William Lotter; James Lindsay; Valentina Santo; Alessio Cortellini; Bijaya Sharma; Kristen Felt; Kathleen Pfaff; Giuseppe Lamberti; Federica Pecci; Alessandro Di Federico; Maisam Makarem; Malini M. Gandhi; Tom Nguyen; Danielle Haradon; Victor R. Vaz; Bruce E. Johnson; Neha Debnath; Yinghong Wang; Andrew G. Kuang; Anwaar Saeed; Maluki Radford; Christine M. Lovly; Caroline A. Nebhan; David J. Pinato; Scott J. Rodig; Adam J. Schoenfeld; Mark M. Awad; Joao V. Alessi; Abdul Rafeh Naqash
Lenvatinib versus sorafenib as a second-line option in patients with unresectable hepatocellular carcinoma previously treated with atezolizumab plus bevacizumab: An observational study

仑伐替尼与索拉非尼作为接受过阿替利珠单抗联合贝伐珠单抗治疗的不切除肝细胞癌患者的二线治疗选择：一项观察性研究

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Lombardi, P.; Manfredi, G. F.; Celsa, C.; Stefanini, B.; Marron, T.; Saeed, A.; Pinter, M.; Ulahannan, S.; Piscaglia, F.; Lin, C-Y.; Dalbeni, A.; Masi, G.; Schoenlein, M.; Galle, P. R.; Kudo, M.; Rimassa, L.; Chon, H.; Pirisi, M.; Pinato, D. J.
Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study
CANCER LETTERS
IF10.1
2024-08-012
OA
Fletcher, Kylie; Cortellini, Alessio; Ganta, Teja; Kankaria, Roma; Song, Haocan; Ye, Fei; Irlmeier, Rebecca; Debnath, Neha; Saeed, Anwaar; Radford, Maluki; Alahmadi, Asrar; Diamond, Akiva; Hoimes, Christopher; Presley, Carolyn J.; Owen, Dwight H.; Abou Alaiwi, Sarah; Nassar, Amin H.; Lamberti, Giuseppe; Perrone, Fabiana; Buti, Sebastiano; Giusti, Raffaele; Filetti, Marco; Vanella, Vito; Mallardo, Domenico; Sussman, Tamara A.; Galetta, Domenico; Kalofonou, Foteini; Daniels, Ella; Ascierto, Paolo A.; Pinato, David J.; Nebhan, Caroline; Berg, Stephanie; Choueiri, Toni K.; Marron, Thomas U.; Wang, Yinghong; Naqash, Abdul Rafeh; Johnson, Douglas B.
Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment

肝功能失代偿是使用阿特珠单抗联合贝伐单抗治疗的肝细胞癌患者死亡率的主要驱动因素: 成功抗病毒治疗的影响

HEPATOLOGY
IF15.8
2024-07-195
PRE
Celsa, Ciro; Cabibbo, Giuseppe; Fulgenzi, Claudia Angela Maria; Battaglia, Salvatore; Enea, Marco; Scheiner, Bernhard; D'Alessio, Antonio; Manfredi, Giulia F.; Stefanini, Bernardo; Nishida, Naoshi; Galle, Peter R.; Schulze, Kornelius; Wege, Henning; Ciccia, Roberta; Hsu, Wei-Fan; Vivaldi, Caterina; Wietharn, Brooke; Lin, Ryan Po-Ting; Pirozzi, Angelo; Pressiani, Tiziana; Dalbeni, Andrea; Natola, Leonardo A.; Auriemma, Alessandra; Rigamonti, Cristina; Burlone, Michela; Parisi, Alessandro; Huang, Yi-Hsiang; Lee, Pei-Chang; Ang, Celina; Marron, Thomas U.; Pinter, Matthias; Cheon, Jaekyung; Phen, Samuel; Singal, Amit G.; Gampa, Anuhya; Pillai, Anjana; Roehlen, Natascha; Thimme, Robert; Vogel, Arndt; Soror, Noha; Ulahannan, Susanna; Sharma, Rohini; Sacerdoti, David; Pirisi, Mario; Rimassa, Lorenza; Lin, Chun-Yen; Saeed, Anwaar; Masi, Gianluca; Schoenlein, Martin; von Felden, Johann; Kudo, Masatoshi; Cortellini, Alessio; Chon, Hong Jae; Camma, Calogero; Pinato, David James

研究方向

暂未获取到该数据
M
Miriam Mérad
H 指数:135论文数:774被引数:9.2万
S
Sacha Gnjatic
H 指数:89论文数:902被引数:4.1万
D
David J. Pinato
H 指数:66论文数:867被引数:1.7万
A
Anwaar Saeed
H 指数:33论文数:408被引数:4,293
S
Seunghee Kim‐Schulze
H 指数:50论文数:561被引数:1.2万
A
Alessio Cortellini
H 指数:51论文数:650被引数:9,132
M
Masatoshi Kudo
H 指数:143论文数:2,840被引数:12.5万
L
Lorenza Rimassa
H 指数:70论文数:769被引数:2.2万
Y
Yi‐Hsiang Huang
H 指数:63论文数:824被引数:2.2万
N
Naqash, Abdul Rafeh
H 指数:0论文数:8被引数:75